IL15 and neoplasm: To examine whether the observed superiority of IL-2/IL-15-expanded Vγ9Vδ2 T cells persists in conditions more resembling those of the tumor microenvironment, we repeated the cytotoxicity assays against ZOL-pre-treated FM-28 cells in hypoxia (1% O2).